IR-related and autophagy-related proteins were detected using western blotting, and IR and autophagy-related genes were analyzed using quantitative real-time polymerase chain reaction
To evaluate its performance, a phase II clinical trial was conducted with 293 patients with a weekly dose of 2.4, 4.8, or 6.0 mg, versus placebo
"It's putting patients in a position where they can easily find a product that they should not be putting inside their body," Kaylor warned, citing concerns about patients turning to unregulated or counterfeit products in the absence of legal compounded versions
Gut Health Targeted treatments and protocols to restore digestive balance, improve absorption, and support overall wellness
Both medications activate the same GLP-1 receptor pathway, meaning combining them intensifies side effects rather than improving results
According to the SmPC, if a patient cannot tolerate the 2.4 mg dose, it may be reduced to 1.7 mg as a maintenance dose